Oct 5 (Reuters) - Amyris Inc :Amyris enters into product development and production agreement with Royal DSM for human nutrition ingredient.Amyris Inc - ‍entered into a product development and production agreement for a new class of human nutrition ingredients with Koninklijke DSM N.V.​.Amyris Inc - partnership announced is focused on developing ingredient for market introduction in 2019.
Full Article

Sept 26 (Reuters) - Amyris Inc :Amyris Inc enters into second major product development and production agreement with Royal DSM.Amyris Inc - ‍has entered into a product development and production agreement for vitamin A with Koninklijke DSM N.V.​.Amyris Inc - DSM is partnering with Amyris to fund development of technology to produce vitamin A​.
Full Article

Aug 3 (Reuters) - Amyris Inc :Amyris announces agreements for $50 million in second tranche of equity financing, exceeding previous target of $95 million.Amyris Inc - ‍second tranche of $50 million in a private placement days is being led by a $25-million investment from Koninklijke DSM N.V.​.Amyris Inc - ‍remaining $25 million of $50 million private placement contributed by Vivo Capital, a healthcare investment firm​.Amyris Inc - ‍following close of tranche, Vivo Capital will be granted an Amyris board seat and DSM gains an additional board seat​.
Full Article

July 17 (Reuters) - Amyris Inc ::Amyris enters into first product development and production agreement with Royal DSM for food and nutrition molecule.Amyris Inc - ‍as part of agreement, DSM will partner with co, fund development of technology to produce specific molecule that co will scale, supply​.
Full Article

July 7 (Reuters) - Amyris Inc ::Amyris Inc - on June 30, 2017, company issued and sold an amended and restated note in principal amount of $3.0 million to purchaser - sec filing.Amyris Inc - in connection with issuance and sale of $3 million note, company and purchaser entered into a letter agreement.Amyris Inc - pursuant to letter agreement, purchaser has right to cause coto redeem all of outstanding principal amount of $3 million note in cash.Amyris Inc - pursuant to letter agreement purchaser has right to cause company to redeem all of outstanding principal amount of $3 million note in cash.
Full Article

June 6 (Reuters) - Amyris Inc :Amyris announces reverse stock split - delivering on strong product revenue growth and execution.Amyris Inc- every 15 pre-split shares of common stock held by stockholders will automatically be converted into one share of common stock.Amyris Inc - co's common stock will begin trading on a split-adjusted basis as of commencement of trading on june 6, 2017.
Full Article

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: